Genetic Technologies Limited
Genetic Technologies Limited (GNTLF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GNTLF · as of Jun 9, 2026
Key Statistics
Explore Genetic Technologies Limited Data
gntlf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
gntlf competitorsGNTLF
CHIZF
CMOPF
CSPHF
EVOTF
MRCHFStock Performance
Full HistoryAbout Genetic Technologies Limited
Genetic Technologies Limited trading as GNTLF, is an Australian molecular diagnostics enterprise dedicated to creating and delivering advanced predictive assessment instruments. These tools are desig…
what is genetic technologies limited · gntlf stock overview · genetic technologies limited company profile · who is genetic technologies limited ceo · gntlf OTC · genetic technologies limited headquarters · genetic technologies limited business segments
About Stock Overview & Key Data
Genetic Technologies Limited (GNTLF) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since Oct 19, 2000. As of the latest trading session, GNTLF stock price is $1.00, with a market capitalization of $1.3B. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Genetic Technologies Limited stock is Sell, with an average 12-month price target of $—. In fiscal year 2024, Genetic Technologies Limited reported revenue of $9.7M and net income of -$12.0M. For detailed data — including Genetic Technologies Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Genetic Technologies Limited (GNTLF) stock price is $1.00. The stock is traded on OTC under the ticker symbol GNTLF. The 52-week range is $1.00 – $1.00.